Poly(I:C) enhances mesenchymal stem cell control of myeloid cells from COVID-19 patients

Mesenchymal stem cells (MSCs) are being studied for the treatment of COVID-19-associated critical illness, due to their immunomodulatory properties. Here, we hypothesized that viral mimic-priming improves MSCs’ abilities to rebalance the dysregulated immune responses in COVID-19. Transcriptome analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Souza-Moreira, Luciana, Tan, Yuan, Wang, Yan, Wang, Jia-Pey, Salkhordeh, Mahmoud, Virgo, Jennifer, Florian, Maria, Murray, Aidan B.P., Watpool, Irene, McIntyre, Lauralyn, English, Shane, Stewart, Duncan J., Mei, Shirley H.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975597/
https://www.ncbi.nlm.nih.gov/pubmed/35402859
http://dx.doi.org/10.1016/j.isci.2022.104188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975597/
https://www.ncbi.nlm.nih.gov/pubmed/35402859
http://dx.doi.org/10.1016/j.isci.2022.104188

Ejemplares similares